Financial Performance - The company's operating revenue for Q1 2025 was CNY 3,282,371,654.33, representing a 14.49% increase compared to CNY 2,866,993,030.25 in the same period last year[4] - Net profit attributable to shareholders was CNY 677,950,685.64, up 7.07% from CNY 633,203,947.14 year-on-year[4] - Basic and diluted earnings per share increased to CNY 0.210, reflecting a growth of 7.14% from CNY 0.196[4] - The net profit for Q1 2025 was CNY 748,532,609.44, an increase of 3.3% compared to CNY 723,100,538.16 in Q1 2024[19] - The total comprehensive income for Q1 2025 was CNY 748,296,509.44, compared to CNY 723,145,867.90 in Q1 2024, indicating a growth of 3.5%[19] Cash Flow - The net cash flow from operating activities was negative at CNY -420,025,067.13, a significant decline of 865.93% compared to CNY 54,838,375.30 in the previous year[4] - The cash flow from operating activities for Q1 2025 was negative at CNY -420,025,067.13, compared to a positive CNY 54,838,375.30 in Q1 2024[21] - The cash flow from investing activities in Q1 2025 was negative at CNY -83,299,331.96, a significant decrease from CNY 390,253,873.24 in Q1 2024[22] - The company incurred a cash outflow of CNY 429,825,934.59 from financing activities in Q1 2025, compared to CNY -12,962.62 in Q1 2024[22] - The cash flow analysis indicates a need for strategic adjustments to improve cash generation and manage outflows effectively[31] Assets and Liabilities - Total assets at the end of the reporting period were CNY 20,935,618,342.09, a 1.44% increase from CNY 20,637,624,991.90 at the end of the previous year[5] - The total liabilities decreased to CNY 2,053,245,358.12 as of March 31, 2025, down from CNY 2,534,198,585.21 at the end of 2024, a reduction of about 19%[16] - The company's equity attributable to shareholders rose by 4.15% to CNY 17,717,927,928.14 from CNY 17,012,676,098.01[5] Inventory and Receivables - Accounts receivable increased by 505.54%, indicating a significant rise in credit sales during the reporting period[7] - Inventory levels rose by 41.61%, reflecting an increase in stock to meet anticipated demand[7] - Inventory levels increased to CNY 560,451,709.40 as of March 31, 2025, compared to CNY 395,763,823.98 at the end of 2024, representing a rise of about 41.6%[14] Research and Development - Research and development expenses for Q1 2025 were CNY 61,686,712.94, compared to CNY 53,119,382.37 in Q1 2024, reflecting an increase of approximately 16.1%[18] - Research and development expenses for Q1 2025 were ¥46,218,413.11, an increase from ¥36,943,748.76 in Q1 2024, reflecting a focus on innovation[27] Market Outlook and Risks - The company emphasized the importance of market expansion and cost control to enhance operational efficiency and profitability[11] - The company remains cautious about market uncertainties and advises investors to be aware of investment risks[12] Financial Management - Non-recurring gains and losses amounted to CNY 30,520,766.92, primarily from government subsidies and other income[6] - The company reported a significant increase in cash received from sales, totaling ¥1,275,343,439.62 in Q1 2025, compared to ¥1,120,058,130.19 in Q1 2024[30] - The company recorded a financial income of ¥21,623,590.07 in Q1 2025, compared to ¥14,992,949.27 in Q1 2024, highlighting better financial management[27] Accounting Standards - The company is set to implement new accounting standards starting in 2025, which may affect future financial reporting[32]

股票代码：601958 股票简称：金钼股份 公告编号： 2025-009 金堆城钼业股份有限公司 关于控股股东增持公司股份计划实施完毕暨 增持结果公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： ●本次增持计划的主要内容：金堆城钼业股份有限公司（以下简称"公 司"）控股股东金堆城钼业集团有限公司（以下简称"金钼集团"）计划 自 2025 年 4 月 9 日起 6 个月内（窗口期顺延），通过上海证券交易所集 中竞价交易系统增持公司无限售流通 A 股股份，累计增持金额不低于 0.7 亿元、不超过 1 亿元。 ●本次增持计划的实施结果：截至 2025 年 4 月 15 日，金钼集团累计 增持公司股份 10,101,539 股，占公司总股本的 0.3131%，增持金额为 9990.058 万元，本次增持计划实施完毕。 2025 年 4 月 15 日，公司收到控股股东金钼集团《关于完成金钼股份 增持计划的告知函》，现将有关情况公告如下： 一、增持主体基本情况 （一）增持主体：金钼集团 （二）增持主体增持前持股数 ...

T (86-29) 8842 2608 E guantaoxa@guantao.com www.guantao.com 陕西省西安市雁塔区团结南路35号 高新新天地广场3号楼35层3501-08 35/F, Building 3, Gaoxin Xintiandi Square, 35 Tuanjie South Road, Yanta District, Xi'an 北京观韬(西安)律师事务所 关于金堆城钥业集团有限公司 2025 年增持金堆城钼业股份有限公司股份的 法律意见书 观意字 2025XA000124 号 陕西省西安市雁塔区团结南路35号 新新天地广场3号楼35层3501-08 /F. Building 3. Gaoxin Xintiandi Square. 35 Tuaniie South Road. Yanta District, Xi'an 北京观韬(西安)律师事务所 关于金堆城钼业集团有限公司 2025 年增持金堆城铜业股份有限公司股份的 法律意见书 观意字 2025XA000124 号 致:金堆城钼业集团有限公司 北京观韬(西安)律师事务所(以下简称"本所")受金堆城钼业集团有限 公司( ...

金堆城钼业股份有限公司 关于董事辞职的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 2025 年 4 月 14 日，金堆城钼业股份有限公司（以下简称"公司"） 董事会收到陈超先生和朱凌云先生提交的书面辞职报告。因工作变动原因， 陈超先生决定辞去公司第五届董事会董事、审计委员会委员职务；因工作 调整原因，朱凌云先生决定辞去公司第五届董事会董事职务。根据《公司 法》《公司章程》有关规定，上述辞职报告自送达公司董事会时生效，陈 超先生不再担任公司第五届董事会董事、审计委员会委员职务；朱凌云先 生不再担任公司第五届董事会董事职务。 股票代码：601958 股票简称：金钼股份 公告编号：2025-008 2025年4月15日 1 根据《公司法》《公司章程》有关规定，陈超先生和朱凌云先生的辞 职未导致公司董事会成员低于法定人数，不会影响董事会的正常运行。公 司将按照《公司章程》规定，尽快增补董事和审计委员会委员。 公司对陈超先生、朱凌云先生在担任公司董事职务期间为公司发展作 出的贡献表示衷心感谢！ 特此公告。 金堆城钼业股份 ...

股票代码：601958 股票简称：金钼股份 公告编号：2025-007 金堆城钼业股份有限公司 关于控股股东增持公司股份暨增持计划的 公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： 首次增持基本情况：公司控股股东金堆城钼业集团有限公司（以 下简称"金钼集团"）于 2025 年 4 月 9 日通过上海证券交易所集中竞价 交易系统，增持公司无限售流通 A 股股份 200 万股，占公司总股本的 0.062%，增持金额为 1898.74 万元。 增持计划的主要内容：金钼集团计划自 2025 年 4 月 9 日起 6 个月 内（窗口期顺延），通过上海证券交易所集中竞价交易系统增持公司无 限售流通 A 股股份，累计增持金额不低于 0.7 亿元、不超过 1 亿元（含 本次增持股份）。 增持计划实施的不确定风险：金钼集团本次增持计划存在因资本 市场情况发生变化，或因增持所需资金未能及时到位等因素导致无法实 施的风险。 一、增持主体的基本情况 （一）增持主体：金钼集团 （二）增持主体本次增持前持股数量及持股比例：本次 ...

金钼股份：控股股东金钼集团增持公司股份并计划未来6个月内继续增持 智通财经4月9日电，金钼股份(601958.SH)公告称，公司控股股东金钼集团于2025年4月9日增持公司无 限售流通A股股份200万股，占公司总股本的0.062%，增持金额为1898.74万元。金钼集团计划自2025年 4月9日起6个月内，通过上海证券交易所集中竞价交易系统增持公司无限售流通A股股份，累计增持金 额不低于0.7亿元、不超过1亿元（含本次增持股份）。金钼集团承诺在增持计划实施期间和增持完成后 6个月内不减持所持有的公司股份。 ...

Core Insights - The company achieved a total operating revenue of 13.571 billion yuan in 2024, representing a year-on-year growth of 17.68% [1][2] - The net profit attributable to shareholders reached 2.983 billion yuan, with a basic earnings per share of 0.92 yuan [1] - The company plans to distribute a cash dividend of 4 yuan per 10 shares, totaling approximately 1.291 billion yuan [1] Financial Performance - The main business revenue was 11.811 billion yuan, with a year-on-year increase of 12.77% and a gross margin of 46.55% [2] - The company completed 104.36% of its annual operational target [2] Market and Industry Context - The molybdenum market remained stable in 2024, with the average international price of molybdenum oxide at 21.3 USD per pound, down 11.76% year-on-year [1] - Domestic molybdenum iron price averaged 233,000 yuan per ton, a decrease of 10.90% year-on-year [1] Strategic Initiatives - The company is focused on becoming a world-class molybdenum leader, emphasizing a "material and equipment integration, high-end green" strategy [1] - The company has developed a comprehensive industrial chain covering mining, smelting, chemical processing, metal processing, research, and trade [2] Production and Innovation - The company achieved record high production levels across its main molybdenum products, with significant increases in various product lines [3] - R&D investment reached 351 million yuan, with 33 patents granted and 50 research projects completed [3] Future Outlook - For 2025, the company targets an operating revenue of 13 billion yuan, focusing on new industry projects and growth points [4] - The company aims to enhance its modern industrial system and governance structure, striving for a "quality, efficiency, and quantity" growth plan [4]

Core Viewpoint - The company reported a revenue of 13.571 billion yuan for 2024, representing a year-on-year increase of 17.68%, while the net profit attributable to shareholders decreased by 3.76% to 2.983 billion yuan [1] Financial Performance - In Q4 2024, the company achieved a revenue of 3.473 billion yuan, which is a slight decrease of 0.89% quarter-on-quarter but an increase of 29.68% year-on-year [1] - The net profit for Q4 2024 was 788 million yuan, showing a quarter-on-quarter increase of 14.49% and a year-on-year increase of 3.32% [1] - The Q4 2024 molybdenum concentrate price was 3,676 yuan per ton, reflecting a quarter-on-quarter decrease of 0.70% but a year-on-year increase of 18.27% [2] Operational Insights - The fluctuation in gross margin may be attributed to changes in the proportion of self-produced ore, with an increase in self-produced ore sales contributing to improved profitability in Q4 [2] - The company plans to enhance its downstream layout, with production of molybdenum powder and molybdenum plate increasing by 12% and 44% respectively, and production of gold-molybdenum wire increasing by 29% in 2024 [2] - R&D expenses significantly increased in Q4 2024, rising by 93.83% to 157 million yuan, indicating a strong commitment to innovation and development [2] Dividend Policy - The company plans to distribute a cash dividend of 4 yuan per 10 shares, totaling 1.29 billion yuan, with a dividend payout ratio of 43%, an increase of 1.63 percentage points year-on-year [3] - Despite a decline in net profit, the dividend amount remains unchanged, reflecting a commitment to high dividend distribution [3] Market Outlook - The company is optimistic about the rising molybdenum prices, with expectations of improved profitability as the steel industry stabilizes and supply chain dynamics evolve [3] - The anticipated recovery in production of 316/duplex stainless steel is expected to alleviate the current price stagnation in molybdenum, providing further upside potential for the company [3] Earnings Forecast - Revenue projections for 2025-2027 are estimated at 14.3 billion, 15.6 billion, and 18.3 billion yuan respectively, with net profits expected to be 3.2 billion, 3.5 billion, and 3.8 billion yuan [4] - The estimated earnings per share (EPS) for the same period are projected to be 0.98, 1.07, and 1.19 yuan, with corresponding price-to-earnings (PE) ratios of 11, 10, and 9 times [4]

4月2日晚间，金钼股份（601958）发布2024年年报，2024年公司实现营业总收入135.71亿元，同比增长 17.68%；实现归母净利润29.83亿元，同比减少3.76%。报告期内，国内外钼市场价格高位运行，公司加 快延链补链强链，紧抓市场机遇，优化产品结构，对内挖潜增效，严控成本费用，顺利完成了年度经营 计划，受钼产品价格较上年同期下跌影响，公司盈利同比略有减少。 2024年，金钼股份通过自主研发，成功实现了特殊规格高纯钼粉、高端钼合金等核心产品的国产化替 代，提升了市场竞争力。全年新开发客户164家，新产品销量300余吨，为销售增长提供了新动力 （300152）。公司与多家知名科研院所、跨国公司开展长期产学研合作，形成了"科学家+工程师+创客 室+工匠"和"专家+工匠"人才创新驱动机制。 公司全年研发投入3.51亿元，研发支出创历史新高。报告期内，公司取得授权专利33件，完成科研项目 50项，获得"三新三小"奖励19项，顺利通过国家高新技术企业复审。公司多项"国之重器"项目取得重大 突破，历史上首次获批2项国家科技重大专项，并承研2项省级科研项目，为公司在高端领域的发展奠定 坚实基础。此外，公司企业 ...

Investment Rating - The report maintains a "Buy" rating for the company [4] Core Views - The company's performance met expectations, with a revenue of 13.571 billion RMB, up 17.68% year-on-year, and a net profit attributable to shareholders of 2.983 billion RMB, down 3.76% year-on-year [1] - The company is increasing its downstream layout and maintaining high investment in R&D, with significant growth in production of molybdenum products [2] - The company plans to distribute a cash dividend of 4 RMB per 10 shares, maintaining a high dividend payout ratio of 43% [3] - The outlook for molybdenum prices is optimistic, with expectations of significant earnings elasticity for the company as it benefits from stable mining operations [3] Summary by Sections Financial Performance - In Q4 2024, the company achieved a revenue of 3.473 billion RMB, a decrease of 0.89% quarter-on-quarter but an increase of 29.68% year-on-year [1] - The gross profit margin fluctuated due to changes in the proportion of self-produced ore, with Q4 gross profit increasing by 8.57% quarter-on-quarter [2] - The company’s revenue for 2025-2027 is projected to be 14.3 billion, 15.6 billion, and 18.3 billion RMB respectively, with net profits of 3.2 billion, 3.5 billion, and 3.8 billion RMB [4] R&D and Operational Strategy - The company is focusing on expanding its downstream processing capabilities, with production of molybdenum powder and molybdenum plate increasing by 12% and 44% respectively [2] - R&D expenses rose significantly, reflecting the company's commitment to innovation and market expansion [2] Dividend Policy - The company plans to maintain its dividend distribution despite a slight decline in net profit, indicating a strong commitment to returning value to shareholders [3] Market Outlook - The report anticipates a recovery in molybdenum prices, driven by industry supply optimization and cost reductions, which could enhance the company's earnings potential [3]